- Home
- TGTX
TGTX
TG Therapeutics Inc.
as 04-18-2025 1:44pm EST
| Founded: | 1993 | Country: | United States |
| Employees: | N/A | City: | NEW YORK |
| Market Cap: | N/A | IPO Year: | 1995 |
| Target Price: | $40.67 | AVG Volume (30 days): | 2.9M |
| Analyst Decision: | Strong Buy | Number of Analysts: | 6 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | 0.15 | EPS Growth: | 68.03 |
| 52 Week Low/High: | $12.93 - $43.32 | Next Earning Date: | 04-30-2025 |
| Revenue: | $329,004,000 | Revenue Growth: | 40.80% |
| Revenue Growth (this year): | 75.63% | Revenue Growth (next year): | 38.17% |
Latest TG Therapeutics Inc. News
TGTX Breaking Stock News: Dive into TGTX Ticker-Specific Updates for Smart Investing
Simply Wall St.
2 days ago
Exploring US High Growth Tech Stocks
Argus Research
4 days ago
TGTX: Raising target price to $41.00
Zacks
9 days ago
TG Therapeutics Shares Rise Almost 30% in 3 Months: Here's Why
GlobeNewswire
9 days ago
TG Therapeutics Announces Data Presentations for BRIUMVI in Multiple Sclerosis at the American Academy of Neurology 2025 Annual Meeting
Argus Research
11 days ago
TGTX: Lowering target price to $37.00
GlobeNewswire
11 days ago
TG Therapeutics Announces Data Presentations for BRIUMVI in Multiple Sclerosis at the American Academy of Neurology 2025 Annual Meeting
GlobeNewswire
12 days ago
TG Therapeutics Announces Two Publications Highlighting BRIUMVI in Medical Journals
Investor's Business Daily
17 days ago
IBD 50 Stock TG Therapeutics Rallies On A Setback For Chief Rival Roche
Compare TGTX vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "TGTX TG Therapeutics Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.